Subhas S S Karki (Subhas S Karki)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Molecular Docking

Endoplasmic Reticulum Stress

Breast Cancer Cells

Top Venues

Molecules (Basel, Switzerland)

Chemistry & biodiversity

KAHER, KLE College of Pharmacy,

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KAHER, KLE College of Pharmacy, May 05 2018

India

Principal :: Pharmaceutical Chemistry

Publications

Snehal Nirgude, null Shahana M V, Febina Ravindran, Sujeet Kumar, Shivangi Sharma, Raghunandan Mahadeva, Anisha Mhatre, Subhas S S Karki, Bibha Choudhary
A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins. Molecules (Basel, Switzerland) 28 (13) (2023)
B Choodamani, Karla G Cano Hernandez, Sujeet Kumar, Ann Maria Tony, Austre Y Schiaffino Bustamante, Renato J Aguilera, Dominique Schols, Chethampadi G Mohan, Subhas S S Karki
Synthesis, Molecular Docking and Preliminary Antileukemic Activity of 4-Methoxybenzyl Derivatives Bearing Imidazo[2,1-b][1,3,4]thiadiazole. Chemistry & biodiversity 18 (2) (2021)
Snehal Nirgude, Raghunandan Mahadeva, Jinsha Koroth, Sujeet Kumar, Kothanahally S Sharath Kumar, Vidya Gopalakrishnan, Subhas S S Karki, Bibha Choudhary
ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models. Molecules (Basel, Switzerland) 25 (19) (2020)